Biogen Idec (BIIB) is reportedly in talks to buy Acorda Therapeutics (ACOR) in order to gain...

|About: Biogen Inc. (BIIB)|By:, SA News Editor

Biogen Idec (BIIB) is reportedly in talks to buy Acorda Therapeutics (ACOR) in order to gain access to an experimental pill for people with multiple sclerosis.